Vaxcyte (PCVX) Insider Trading & Ownership $85.96 -1.12 (-1.29%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vaxcyte (NASDAQ:PCVX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$33.41 M Get PCVX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxcyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PCVX Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Vaxcyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/7/2024Grant PickeringCEOSell2,366$103.89$245,803.74 11/1/2024Grant PickeringCEOSell15,000$106.82$1,602,300.00 11/1/2024Jim WassilCOOSell8,000$106.80$854,400.00 10/18/2024Andrew GuggenhimeCFOSell42,000$115.39$4,846,380.00 10/7/2024Grant PickeringCEOSell7,098$109.21$775,172.58 10/7/2024Mikhail EydelmanSVPSell5,000$109.27$546,350.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/18/2024Andrew GuggenhimeCFOSell8,000$115.94$927,520.00 9/3/2024Elvia CowanSVPSell5,000$107.67$538,350.00 9/3/2024Jim WassilCOOSell10,000$111.93$1,119,300.00 8/23/2024Grant PickeringCEOSell15,000$78.98$1,184,700.00 7/23/2024Grant PickeringCEOSell15,000$84.26$1,263,900.00 7/18/2024Andrew GuggenhimeCFOSell8,000$81.17$649,360.00 7/16/2024Elvia CowanSVPSell5,000$85.00$425,000.00 7/8/2024Elvia CowanSVPSell5,000$80.00$400,000.00 7/1/2024Grant PickeringCEOSell2,616$76.33$199,679.28 7/1/2024Jim WassilCOOSell3,000$76.34$229,020.00 7/1/2024Mikhail EydelmanSVPSell1,667$76.37$127,308.79 6/24/2024Grant PickeringCEOSell15,000$75.64$1,134,600.00 6/3/2024Grant PickeringCEOSell2,616$72.06$188,508.96 6/3/2024Halley E GilbertDirectorSell18,200$73.00$1,328,600.00 6/3/2024Jim WassilCOOSell3,000$71.99$215,970.00 6/3/2024Mikhail EydelmanSVPSell1,667$72.06$120,124.02 5/23/2024Grant PickeringCEOSell15,000$69.43$1,041,450.00 5/20/2024Andrew GuggenhimeCFOSell8,000$74.99$599,920.00 4/23/2024Grant PickeringCEOSell15,000$61.92$928,800.00 4/18/2024Andrew GuggenhimeCFOSell8,000$61.27$490,160.00 3/25/2024Grant PickeringCEOSell15,000$66.93$1,003,950.00 3/18/2024Andrew GuggenhimeCFOSell8,000$69.02$552,160.00 3/1/2024Elvia CowanSVPSell11,678$74.08$865,106.24 3/1/2024Grant PickeringCEOSell2,616$73.70$192,799.20 3/1/2024Jim WassilCOOSell3,000$73.71$221,130.00 2/1/2024Grant PickeringCEOSell2,616$73.91$193,348.56 2/1/2024Jim WassilCOOSell3,000$73.88$221,640.00 2/1/2024Mikhail EydelmanSVPSell1,667$73.87$123,141.29 1/31/2024Heath LukatchDirectorSell5,000$71.50$357,500.00 1/29/2024Grant PickeringCEOSell30,000$66.03$1,980,900.00 1/29/2024Heath LukatchDirectorSell4,000$67.50$270,000.00 1/23/2024Grant PickeringCEOSell15,000$63.92$958,800.00 1/18/2024Andrew GuggenhimeCFOSell8,000$60.73$485,840.00 1/2/2024Grant PickeringCEOSell2,616$63.89$167,136.24 New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now!1/2/2024Heath LukatchDirectorSell13,000$63.76$828,880.00 1/2/2024Jim WassilCOOSell3,000$63.91$191,730.00 1/2/2024Mikhail EydelmanSVPSell1,667$63.93$106,571.31 12/26/2023Grant PickeringCEOSell15,000$61.70$925,500.00 12/18/2023Andrew GuggenhimeCFOSell8,000$60.18$481,440.00 12/7/2023Mikhail EydelmanSVPSell10,000$56.50$565,000.00 11/24/2023Grant PickeringCEOSell15,000$49.09$736,350.00 (Data available from 1/1/2013 forward) PCVX Insider Trading Activity - Frequently Asked Questions Who is on Vaxcyte's Insider Roster? The list of insiders at Vaxcyte includes Andrew Guggenhime, Elvia Cowan, Grant Pickering, Halley E Gilbert, Heath Lukatch, Jeff Fairman, Jim Wassil, Mikhail Eydelman, and Paul Sauer. Learn more on insiders at PCVX. What percentage of Vaxcyte stock is owned by insiders? 3.10% of Vaxcyte stock is owned by insiders. Learn more on PCVX's insider holdings. Which Vaxcyte insiders have been selling company stock? The following insiders have sold PCVX shares in the last 24 months: Andrew Guggenhime ($9,809,100.00), Elvia Cowan ($2,228,456.24), Grant Pickering ($16,472,303.34), Halley E Gilbert ($1,328,600.00), Heath Lukatch ($1,485,624.35), Jim Wassil ($3,504,720.00), and Mikhail Eydelman ($2,596,495.41). How much insider selling is happening at Vaxcyte? Insiders have sold a total of 502,976 Vaxcyte shares in the last 24 months for a total of $37,425,299.34 sold. Vaxcyte Key ExecutivesMr. Grant E. Pickering M.B.A. (Age 56)Co-Founder, CEO & Director Compensation: $1.13MMr. Andrew L. Guggenhime M.B.A. (Age 56)President & CFO Compensation: $820.81kMr. James Wassil M.B.A. (Age 55)M.S., Executive VP & COO Compensation: $521.05kMr. Mikhail Eydelman J.D. (Age 42)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Compensation: $684.62k3 recent tradesDr. Ashish Khanna M.B.A. (Age 52)Ph.D., Co-Founder Dr. Jeff Fairman Ph.D. (Age 60)Co-Founder & VP of Research Ms. Elvia Cowan (Age 51)Senior VP of Finance & Principal Accounting Officer 3 recent tradesMs. Janet GraesserSenior Vice President of Corporate Communications & Investor RelationsMs. Whitney JonesChief People OfficerMr. Paul W. Sauer M.B.A. (Age 63)Senior Vice President of Process Development & Manufacturing Compensation: $608.96k More Insider Trading Tools from MarketBeat Related Companies Scholar Rock Insider Buying Sangamo Therapeutics Insider Buying Editas Medicine Insider Buying Adverum Biotechnologies Insider Buying Atara Biotherapeutics Insider Buying Cortexyme Insider Buying Takeda Pharmaceutical Insider Buying BioNTech Insider Buying Teva Pharmaceutical Industries Insider Buying BeiGene Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:PCVX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCVX Stock Alerts